The complexities of chronic post-traumatic headache (CPTH) date back to its initial recognition. By the mid-1800s the persistence of headache after head injury was acknowledged as a manifestation of brain injury or 'molecular derangement.' However, with the advent of financial compensation for these injuries, the psychologic aspects were thought to be predominant, hence such terms as 'compensation neurosis.' The latter concept persisted into the early decades of the 20th century with more sophisticated terms as 'somatization' and 'conversion disorder'.
Paradoxically, CPTH is more common after mild head trauma than following moderate or severe injury. 5, 6 The reason for this is speculative.
Perhaps patients are more focused on the signs of cerebral contusion, laceration, or hemorrhage than on the symptom of headache. Perhaps psychologic and socioeconomic factors are more likely to smolder and bloom when the function of patients is impaired by headache and there are no physical signs to prove their illness to others.
Clinical Features
As indicted by the IHCD criteria, there are no distinctive features of CPTH. Any symptoms of the primary headaches may be manifest.
The most common phenotypical presentation is chronic tension-type headache, which occurs in about 80% of cases. 7 Post-traumatic migraine is much less common and may co-exist with tension-type headache. The onset of cluster headache has been reported after head trauma and there are rare reports of hemicrania continua, chronic paroxysmal hemicrania, and short-lasting unilateral neuralgiform headache attacks with conjunctional injection and tearing (SUNCT) syndrome associated with head injury. The occurrence of CPTH is greater among people with a past history of headaches or a prior head injury, although these conclusions may be skewed by recall bias. 8, 9 CPTH is often associated with other post-traumatic syndromes. Most common are the post-concussion and post-traumatic syndromes (the two phrases are often used interchangeably 14 The injury may also evoke changes in cerebral metabolism or in intracranial hemodynamics or both. 15, 16 Excitatory amino acids and inhibitory neurotransmitters may be released; changes in endogenous opioids and nitrous oxide activity may occur. If these changes lead to CPTH, the mechanism is unknown, but the pathophysiology is probably the same as that of other chronic pain syndromes, wherein peripheral sensitization leads to central sensitization, abnormal pain processing, and the development of a self-perpetuating vicious cycle.
CPTH has been studied using many modalities. Standard tests and imaging studies are usually normal. Electroencephalography sometimes reveals asynchormous abnormal slow activity. 17 Single-photon emission computed tomography (SPECT) has shown decreased cerebral blood flow and abnormally asymmetrical regional blood flow. 18 Brain auditory evoked responses revealed alteration and prolonged latency of some components. 19 PET showed a decrease in the metabolic rate of glucose, and other studies revealed release of inhibitory neurotransmitters and excitatory amino acids. 15, 16, 20 MRI sometimes showed cerebral parenchymal lesions. 21 Volumetric changes on MRI correlated with the degree of trauma. 22 None of these studies is a specific biomarker of CPTH or of chronic cerebral trauma.
A recent advance in MRI DTI measures the neurostructure of white-matter integrity. 10, 11, 23, 24 An increase in fractional anisotropy appears to reflect cytotoxic edema or axonal swelling, while a decrease in fractional anisotropy is thought to indicate axonal degradation or gliosis. Studies soon after head injury revealed increased fractional anisotropy with decreased radial diffusivity; the changes then normalized after three to five months, 11 while another study found Expectation of pain may be a self-fulfilling prophesy. After a mild head injury, those patients who believed their symptoms would have serious consequences were at greatest risk for prolonged post-concussion syndrome. 27 This result was unrelated to the severity of the injury, anxiety or depression. Expectations of pain and disability are greatly influenced by culture. Americans who had not experienced head trauma were asked to imagine symptoms that would be expected six months after a motor vehicle accident. 28 Their answers were similar to a group who had a head injury. Both groups reported symptoms of post-concussion syndrome; headache was at the top of the list, although the methodology of this study has been questioned. 29 Canadians and Lithuanians who had not been injured were asked a similar question. and Greeks were also much lower than in Canadians. 31, 32 Social and economic factors may play a role in CPTH. In evaluating patients with disability following head injury, 79% of those with mild head injury had headaches after three months. 33 In those with longer-term disability there had been lower levels of education, employment, and income; higher levels of life stresses were also noted in this group.
Although malingering is not common, the relationship of secondary gain to CPTH is problematic. Most people with head and neck injury return to work before litigation is settled, and CPTH as well as other symptoms often persist after a favorable verdict. 34 On the other hand, in litigation "if you have to prove you are ill, you cannot get well." 35 After head injury, those with financial motives had more symptoms and disabilities than those in a control group. 36 In people hospitalized for postconcussion syndrome, the duration of work loss was much greater in those who claimed compensation than those who did not. 37 In Lithuania and Greece, where litigation is minimal, there is a low prevalence of post-traumatic symptoms. 30, 38 The best prognosis in people with whiplash injuries was noted in those societies that have the fewest disability payments, no compensation for pain and suffering, and little litigation. 26 In summary, the many organic, psychologic and external factors that may play a part in the development of PCTH are inextricably interwoven.
Treatment
The treatment of CPTH is similar to that of the primary headaches.
Chronic tension-type headache is the most common manifestation of CPTH. A combination of pharmacologic and non-pharmacologic treatment modalities is superior to either one alone.
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Of the pharmacologic agents, tricyclic agents such as nortripyline are the initial drugs of choice. All of the prophylactic agents used for chronic migraine may be tried including the antiepileptic agents (topiramate and divalproex), beta adrenergic blockers, and newer antidepressants.
Exacerbations of headaches may be treated with triptans if the symptoms are those of migraine or with analgesics including opioids if necessary. As CPTHs occur daily or almost daily, the overuse of analgesics or other agents for acute headache is a major concern.
Acute agents must be limited to two days per week to prevent the rebound perpetuation of daily headache (exceptions to this rule may be occasionally necessary). Occipital nerve blocks may be helpful.
Hospitalization may be advisable to withdraw the patient from the overuse of analgesics including opioids, or for therapy with intravenous dihydroergotamine or other agents. Associated symptoms of depression, anxiety, and insomnia may aggravate and perpetuate CPTH.
Treatment of these conditions may markedly improve the patient's quality of life.
Non-pharmacologic measures are at least as important as drugs for the treatment of CPTH. As headache and other pain syndromes involve interactions of biology, behavior, emotions, cognition, and environmental factors, the concept and techniques of behavioral medicine are invaluable. 40 The evidence-based data and meta-analyses regarding behavioral medicine for headache have recently been summarized. 40 The non-pharmacologic treatments include cognitive behavioral therapy, bio-behavioral training (biofeedback, relation training, stress management), education including lifestyle modification, and physical therapies. All are designed to enhance personal control. 
